NCI Plan

In making the Centers of Cancer Nanotechnology Excellence awards, the NCI is recognizing the scientific merit and clinical promise of the research projects, as well as the strength of the multidisciplinary teams, which include researchers from the public and private sectors that have come together to participate in these Alliance programs. These highly integrated centers will engage in directed, product-focused research that will aim to translate cutting-edge science and technology into the next generation of diagnostic and therapeutic tools that will ultimately benefit cancer patients.

Nanotechnology represents a wide range of scientific endeavors and tools, and the CCNE awards reflect that broad cross-section of technologies and disciplines being applied by teams distributed geographically across the United States, with applications across the entire spectrum of cancers and cancer patients. The selected CCNEs will engage in a range of near-term projects that are approaching clinical use, as well as cutting-edge projects that will have an exceptionally significant impact on clinical oncology if they are brought to fruition.

The new NCI Alliance for Nanotechnology in Cancer is the functional outworking of the Cancer Nanotechnology Plan (CNPlan), which was developed by the Cancer Nanotechnology Working Group over the past 18 months with the input of a broad cross-section of the cancer research and clinical oncology communities. The CNPlan describes how to accelerate the application of nanotechnology to cancer research and clinical care, emphasizing the need for cross-disciplinary and cross-sector collaboration to develop and deliver the public health benefits.

(Click here to download)